Abstract:BACKGROUND:Endostatin (ES) inhibits endothelial cell proliferation, migration, invasion, and tube formation. It also shows antiangiogenesis and antitumor activities in several animal models. Endostatin specifically targets tumor vasculature to block tumor growth. Lidamycin (LDM), which consists of an active enediyne chromophore (AE) and a non-covalently bound apo-protein (LDP), is a member of chromoprotein family of antitumor antibiotics with extremely potent cytotoxicity to cancer cells. Therefore, we reasoned that endostatin-lidamycin (ES-LDM) fusion proteins upon energizing with enediyne chromophore may obtain the combined capability targeting tumor vasculature and tumor cell by respective ES and LDM moiety.METHODS:In this study, we designed and obtained two new endostatin-based fusion proteins, endostatin-LDP (ES-LDP) and LDP-endostatin (LDP-ES). In vitro, the antiangiogenic effect of fusion proteins was determined by the wound healing assay and tube formation assay and the cytotoxicity of their enediyne-energized analogs was evaluated by CCK-8 assay. Tissue microarray was used to analyze the binding affinity of LDP, ES or ES-LDP with specimens of human lung tissue and lung tumor. The in vivo efficacy of the fusion proteins was evaluated with human lung carcinoma PG-BE1 xenograft and the experimental metastasis model of 4T1-luc breast cancer.RESULTS:ES-LDP and LDP-ES disrupted the formation of endothelial tube structures and inhibited endothelial cell migration. Evidently, ES-LDP accumulated in the tumor and suppressed tumor growth and metastasis. ES-LDP and ES show higher binding capability than LDP to lung carcinoma; in addition, ES-LDP and ES share similar binding capability. Furthermore, the enediyne-energized fusion protein ES-LDP-AE demonstrated significant efficacy against lung carcinoma xenograft in athymic mice.CONCLUSIONS:The ES-based fusion protein therapy provides some fundamental information for further drug development. Targeting both tumor vasculature and tumor cells by endostatin-based fusion proteins and their enediyne-energized analogs probably provides a promising modality in cancer therapy.

Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Improved Stability and Enhanced Anti-Tumor Activity of Hyaluronic Acid Modified ES2-AF Nanoparticle-Like Conjugate

The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer.

Endostar Enhances the Antitumor Effects of Radiation by Affecting Energy Metabolism and Alleviating the Tumor Microenvironment in a Lewis Lung Carcinoma Mouse Model.

Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy

Effect of Endostar Combined with Radiotherapy on the Expression of HIF-1α,AQP1 and VEGF in the Mice with Lung Caner

Effect of combining endostatin and radiation on growth inhibiting and apoptosis of A549 cell line

Lung Cancer Cellular Apoptosis Induced by Recombinant Human Endostatin Gold Nanoshell-Mediated Near-Infrared Thermal Therapy

Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: Experimental and clinical evidence

Genetically Engineered Endostatin-Lidamycin Fusion Proteins Effectively Inhibit Tumor Growth and Metastasis

Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin.

Anticancer Treatment of Endostatin Gene Therapy by Targeting Tumor Neovasculature in C57/BL Mice.

Recombinant Human Endostatin Combined with Radiotherapy in the Treatment of Brain Metastases of Non-Small Cell Lung Cancer

Hyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseases

The Effect of rh-Endostatin in Combination with Radiotherapy on the Tumor Growth and VEGF Expression in Mice with Lung Cancer

Effects of the Anti-Angiogenic Carbohydrate-Peptide Conjugate, Chitooligosaccharide-Es2 on Endothelial Cells and Tumor-Bearing Mice.

Microbubble-Enhanced Ultrasound Exposure Improves the Antiangiogenic Effects of Endostar-Loaded Thermosensitive Hydrogel on Triple Negative Breast Cancer Xenograft

[Effects of rh-endostar in combination with radiotherapy on rats with lung cancer].

[Inhibitory Effect of Recombinant Human Endostatin on Angiogenesis and Lung Metastasis of Mouse Lung Adenocarcinoma LA795].

[Effects of Endostatin on the Growth and Lymphangiogenesis of Lewis Lung Carcinoma Xenograft in Mice].